Prevention of Epstein-Barr virus lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

J.W.J van Esser, H.G.M. Niesters, B. van der Holt, E. Meijer, A.D.M.E. Osterhaus, J.W. Gratama, L.F. Verdonck, B. Lowenberg, J.J. Cornelissen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)4364-4369
Number of pages6
JournalBlood
Volume99
Publication statusPublished - 2002

Cite this